2022 Revenues ($USD) : $5,212,000,000
2022 R&D spend : $356,000,000
2022 Number of Employees : 18,369
Fiscal Year End : 12/31/2021
Company CEO : Deepak Nath, CEO
In other recent news, the British medtech giant announced that it will build a new R&D and manufacturing facility for its Advanced Wound Management franchise that will move the company outside of its historic home of Hull. –CN